Nguyen H. Chau
Ho Chi Minh City, SG, Viet Nam
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Changing genetic profiles of Plasmodium falciparum piperaquine resistance in Southeast Asia over 25 years.
Journal: Antimicrobial agents and chemotherapy
Published: February 17, 2026
Population pharmacokinetics of artemether-lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria.
Journal: British journal of clinical pharmacology
Published: May 21, 2025
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.
Journal: PLoS medicine
Published: May 07, 2024
Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD Screening.
Journal: Pathogens (Basel, Switzerland)
Published: July 11, 2023
Lineage-informative microhaplotypes for spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Journal: medRxiv : the preprint server for health sciences
Published: March 30, 2023
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial.
Journal: BMC medical research methodology
Published: March 20, 2023
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
Journal: PLoS neglected tropical diseases
Published: March 04, 2023
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.
Journal: Wellcome open research
Published: April 08, 2022
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria.
Journal: Communications biology
Published: December 01, 2021
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.
Journal: The Lancet. Infectious diseases
Published: September 06, 2021
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Journal: The Lancet. Child & adolescent health
Published: July 26, 2021
Last Updated: 09/26/2026